Cargando…

Molecular binding studies of anthocyanins with multiple antiviral activities against SARS-CoV-2

BACKGROUND: The search for ideal drugs with absolute antiviral activity against SARS-CoV-2 is still in place, and attention has been recently drawn to natural products. Several molecular targets have been identified as points of therapeutic intervention. The targets used in this study include SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akinnusi, Precious Ayorinde, Olubode, Samuel Olawale, Salaudeen, Wasiu Adeboye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006501/ https://www.ncbi.nlm.nih.gov/pubmed/35431537 http://dx.doi.org/10.1186/s42269-022-00786-0

Ejemplares similares

Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma
por: Akinnusi, Precious Ayorinde, et al.
Publicado: (2023)

Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment
por: Akinnusi, Precious A, et al.
Publicado: (2022)

Molecular Modeling Studies of Natural Inhibitors of Androgen Signaling in Prostate Cancer
por: Olubode, Samuel O, et al.
Publicado: (2022)

Potential Inhibitory Biomolecular Interactions of Natural Compounds With Different Molecular Targets of Diabetes
por: Akinnusi, Precious A, et al.
Publicado: (2023)

Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2
por: Grosche, Victória Riquena, et al.
Publicado: (2023)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Antiviral Effect of Budesonide against SARS-CoV-2
por: Heinen, Natalie, et al.
Publicado: (2021)

Theory and reality of antivirals against SARS-CoV-2
por: Zhao, Bo, et al.
Publicado: (2021)

Antiviral Efficacy of Pralatrexate against SARS-CoV-2
por: Bae, Joon-Yong, et al.
Publicado: (2021)

Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation
por: El-hoshoudy, A.N.
Publicado: (2020)

Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
por: Sakib, Md Minhas Hossain, et al.
Publicado: (2021)

Potential Antiviral Options against SARS-CoV-2 Infection
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Lack of antiviral activity of darunavir against SARS-CoV-2
por: De Meyer, Sandra, et al.
Publicado: (2020)

First-generation oral antivirals against SARS-CoV-2
por: Sendi, Parham, et al.
Publicado: (2022)

Potential antiviral peptides against the nucleoprotein of SARS-CoV-2
por: Mahdi, Iktedar, et al.
Publicado: (2022)

Potential antiviral effects of pantethine against SARS-CoV-2
por: Abou-Hamdan, M., et al.
Publicado: (2023)

Malaria patients in Nigeria: Data exploration approach
por: Adeboye, Nureni Olawale, et al.
Publicado: (2019)

Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study
por: Peele, K. Abraham, et al.
Publicado: (2020)

Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection
por: Liu, Xiao-huan, et al.
Publicado: (2021)

Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
por: Mahmud, Shafi, et al.
Publicado: (2021)

Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins
por: Balasubramaniam, Meenakshisundaram, et al.
Publicado: (2020)

Multi-target direct-acting SARS-CoV-2 antivirals against the nucleotide-binding pockets of virus-specific proteins
por: Rani, Ruchi, et al.
Publicado: (2022)

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
por: Essa, Raahilah Zahir, et al.
Publicado: (2022)

Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2
por: Carrouel, F., et al.
Publicado: (2020)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

An in vitro antiviral activity of iodine complexes against SARS-CoV-2
por: Altaf, Imran, et al.
Publicado: (2021)

Antiviral effect of mouthwashes against SARS-COV-2: A systematic review
por: Mezarina Mendoza, Jhon Paul Iakov, et al.
Publicado: (2022)

Boron enhances the antiviral activity of the curcumin against SARS-CoV-2
por: Scorei, Ion Romulus, et al.
Publicado: (2020)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
por: Tonk, Miray, et al.
Publicado: (2021)

In silico evidence of beauvericin antiviral activity against SARS-CoV-2
por: Al Khoury, Charbel, et al.
Publicado: (2022)

Antiviral Activity of Zinc Oxide Nanoparticles against SARS-CoV-2
por: Wolfgruber, Stella, et al.
Publicado: (2023)

In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2
por: Villalobos-Sánchez, Erendira, et al.
Publicado: (2023)

Antiviral activity of salt-coated materials against SARS-CoV-2
por: Coleman, Christopher M., et al.
Publicado: (2023)

Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies
por: Al-Rabia, Mohammed W., et al.
Publicado: (2021)

In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
por: Khater, Ibrahim, et al.
Publicado: (2021)

Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
por: Calligari, Paolo, et al.
Publicado: (2020)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2
por: Dömötör, Orsolya, et al.
Publicado: (2023)

Berries anthocyanins as potential SARS-CoV–2 inhibitors targeting the viral attachment and replication; molecular docking simulation
por: Messaoudi, Omar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l2ht6iq9j7pak7m4p6nu80og3n